Grantham, Mayo, Van Otterloo & Co. LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1352662 Boston, MA

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$12,207,352

+$7,513,983 QoQ

Shares Held

72,430

+103.3% QoQ

Ownership

0.071%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#144

of 768 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Grantham, Mayo, Van Otterloo & Co. LLC holds $28,929,984 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (42.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	1,486,022	$13,864,585
2	NBIX	Neurocrine Biosciences Inc This page	72,430	$12,207,352
3	UTHR	UNITED THERAPEUTICS Corp	3,277	$1,775,576
4	ZTS	Zoetis Inc.	10,345	$743,391
5	RDY	Dr Reddys Laboratories Ltd	23,401	$339,080

All Filings in NBIX

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,207,352	72,430	+103.3%	Shares	Sole	2026-08-13
2026-03-31	$4,693,369	35,626	+399.5%	Shares	Sole	2026-05-14
2025-12-31	$1,011,673	7,133	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.